logo

For the Inventor, By the Inventor

Seoul, South Korea

Gencurix Inc

USPTO Granted Patents = 10


Trademarks = 2

Forward Citations = 5

Loading Chart...
Loading Chart...

22 inventors (with patents filed for the assignee):

goldMedal Young Kee Shin (10 out of 24 patents)

silverMedal En Sel Oh (5 out of 5 patents)

bronzeMedal Young Ho Moon (5 out of 7 patents)

4.  Yong Ho In (3 out of 3 patents)

5.  Mi Jeong Kwon (3 out of 3 patents)

6.  Sang Seok Koh (3 out of 3 patents)

7.  Jin Il Han (3 out of 3 patents)

8.  Sang Rae Cho (3 out of 11 patents)

9.  Young-Deug Kim (2 out of 5 patents)

10.  Sang Rea Cho (2 out of 2 patents)

11.  Jee Eun Kim (2 out of 3 patents)

12.  Bohyun Byun (1 out of 1 patent)

13.  Hyunjeung Choi (1 out of 1 patent)

14.  Joon Seok Choi (1 out of 1 patent)

15.  Myungsun Kim (1 out of 6 patents)


10 patents:

1. 11970732 - Method for determining nucleic acid quality of biological sample (2024-04-30),
2. 11840733 - Method for predicting prognosis of breast cancer patient (2023-12-12),
3. 11261482 - Composition for detecting epidermal cell growth factor receptor gene mutation, and kit comprising same (2022-03-01),
4. 11220716 - Methods for predicting the prognosis of breast cancer patient (2022-01-11),
5. 11107552 - Data processing, analysis method of gene expression data to identify endogenous reference genes (2021-08-31),
6. 10718030 - Methods for predicting effectiveness of chemotherapy for a breast cancer patient (2020-07-21),
7. 10655187 - Genetic marker for early breast cancer prognosis prediction and diagnosis, and use thereof (2020-05-19),
8. 10428386 - Gene for predicting the prognosis for early-stage breast cancer, and a method for predicting the prognosis for early-stage breast cancer by using the same (2019-10-01),
9. 10304561 - Data processing, analysis method of gene expression data to identify endogenous reference genes (2019-05-28),
10. 9639660 - Data processing, analysis method of gene expression data to identify endogenous reference genes (2017-05-02),
Company Overview
Gencurix Inc, based in Seoul, specializes in the development of innovative diagnostic solutions, particularly in the field of personalized medicine. The company focuses on utilizing advanced genomic technologies to enhance cancer detection and treatment, aiming to improve patient outcomes through tailored therapeutic strategies. Gencurix is committed to advancing healthcare by integrating cutting-edge research with practical applications in diagnostics, thereby contributing to the evolving landscape of medical technology.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

10 Patents

#399 in Seoul

#1,092 in South Korea

#56,092 in the World

Seoul, KR
Seoul, South Korea

Gencurix Inc

Forward Citations = 5

22 inventors:

goldMedal Young Kee Shin (10 out of 24 patents)

silverMedal En Sel Oh (5 out of 5 patents)

bronzeMedal Young Ho Moon (5 out of 7 patents)

4.  Yong Ho In (3 out of 3 patents)

5.  Mi Jeong Kwon (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Gencurix Inc. Retrieved from https://idiyas.com/company/gencurix

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…